Bogart Wealth LLC’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.54K Buy
+155
New +$1.3K ﹤0.01% 1528
2024
Q2
– Sell
-36
Closed -$1.68K – 1130
2024
Q1
$1.68K Buy
36
+17
+89% +$880 ﹤0.01% 925
2023
Q4
$1.27K Buy
+19
New +$1.16K ﹤0.01% 942

Other funds holding DNA

Bogart Wealth LLC's DNA Position: Q2 2026 in Review

Bogart Wealth LLC opened a new position in Ginkgo Bioworks (DNA) in Q2 2026: 155 shares worth $1.54K. The stake represents ﹤0.01% of the portfolio and ranks #1528 among its holdings. This is a return to the name: Bogart Wealth LLC previously reported a position in DNA as recently as Q1 2024.

Bogart Wealth LLC first reported a position in DNA in Q4 2023 and has held it in 3 quarters since. The position peaked at $1.68K in Q1 2024. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Bogart Wealth LLC held 155 shares of Ginkgo Bioworks worth $1.54K as of Q2 2026.
  • Ginkgo Bioworks was a new Bogart Wealth LLC position in Q2 2026.
  • Ginkgo Bioworks made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #1528 holding.
  • Bogart Wealth LLC first reported a position in Ginkgo Bioworks in Q4 2023 and has held it in 3 quarters since.
  • Bogart Wealth LLC's Ginkgo Bioworks position peaked at $1.68K in Q1 2024.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.